Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 15;78(20):5723-5728.
doi: 10.1158/0008-5472.CAN-18-1600. Epub 2018 Aug 17.

Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How

Affiliations
Review

Promoting Scientist-Advocate Collaborations in Cancer Research: Why and How

Jeannine M Salamone et al. Cancer Res. .

Abstract

Advocates bring unique and important viewpoints to the cancer research process, ensuring that scientific and medical advances are patient-centered and relevant. In this article, we discuss the benefits of engaging advocates in cancer research and underscore ways in which both the scientific and patient communities can facilitate this mutually beneficial collaboration. We discuss how to establish and nurture successful scientist-advocate relationships throughout the research process. We review opportunities that are available to advocates who want to obtain training in the evaluation of cancer research. We also suggest practical solutions that can strengthen communication between scientists and advocates, such as introducing scientist-advocate interactions at the trainee level. Finally, we highlight the essential role social media can play in disseminating patient-supported cancer research findings to the patient community and in raising awareness of the importance of promoting cancer research. Our perspective offers a model that Georgetown Breast Cancer Advocates have found effective and which could be one option for those interested in developing productive, successful, and sustainable collaborations between advocates and scientists in cancer research. Cancer Res; 78(20); 5723-8. ©2018 AACR.

PubMed Disclaimer

Conflict of interest statement

Disclosure of Potential Conflicts of Interest

R. Carlin is Executive Director at American Association on Health and Disability. No potential conflicts of interest were disclosed by the other authors.

Figures

Figure 1.
Figure 1.
Comprehensive approach for promoting scientist–advocate collaboration at a cancer research institution. Leadership directly supports the education and training of advocates and scientists (including students) to work together as partners in the research process. That can lead to patient-focused research goals and increased dissemination and awareness of cancer research and findings. Collectively, the impact on the community through better research outcomes can promote the overall mission of the cancer research institute, thus creating a sustainable scientist–advocate collaboration for current and future generations.

References

    1. Perlmutter J, Roach N, Smith ML. Involving advocates in cancer research. Semin Oncol 2015;42:681–5. - PubMed
    1. Perlmutter J, Bell SK, Darien G. Cancer research advocacy: past, present, and future. Cancer Res 2013;73:4611–5. - PubMed
    1. Finn R Surveys identify barriers to participation in clinical trials. J Natl Cancer Inst 2000;92:1556–8. - PubMed
    1. Tejeda HA, Green SB, Trimble EL, Ford L, High JL, Ungerleider RS, et al. Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials. J Natl Cancer Inst 1996;88:812–6. - PubMed
    1. Lewis JH, Kilgore ML, Goldman DP, Trimble EL, Kaplan R, Montello MJ, et al. Participation of patients 65 years of age or older in cancer clinical trials. J Clin Oncol 2003;21:1383–9. - PubMed

Publication types